vs
Side-by-side financial comparison of FrontView REIT, Inc. (FVR) and Valneva SE (VALN). Click either name above to swap in a different company.
Valneva SE is the larger business by last-quarter revenue ($36.2M vs $18.2M, roughly 2.0× FrontView REIT, Inc.). FrontView REIT, Inc. runs the higher net margin — 2.2% vs -54.1%, a 56.3% gap on every dollar of revenue.
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States.
FVR vs VALN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2023
| Metric | | |
|---|---|---|
| Revenue | $18.2M | $36.2M |
| Net Profit | $400.0K | $-19.6M |
| Gross Margin | — | 38.9% |
| Operating Margin | 24.9% | -49.5% |
| Net Margin | 2.2% | -54.1% |
| Revenue YoY | 12.0% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $18.2M | — | ||
| Q4 25 | $16.5M | — | ||
| Q3 25 | $16.8M | — | ||
| Q2 25 | $17.6M | — | ||
| Q1 25 | $16.2M | — | ||
| Q3 24 | $14.5M | — | ||
| Q1 23 | — | $36.2M | ||
| Q2 22 | — | $93.2M |
| Q1 26 | $400.0K | — | ||
| Q4 25 | $-4.1M | — | ||
| Q3 25 | $4.0M | — | ||
| Q2 25 | $-2.9M | — | ||
| Q1 25 | $-833.0K | — | ||
| Q3 24 | $-2.4M | — | ||
| Q1 23 | — | $-19.6M | ||
| Q2 22 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q1 23 | — | 38.9% | ||
| Q2 22 | — | — |
| Q1 26 | 24.9% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q1 23 | — | -49.5% | ||
| Q2 22 | — | -161.3% |
| Q1 26 | 2.2% | — | ||
| Q4 25 | -24.9% | — | ||
| Q3 25 | 23.9% | — | ||
| Q2 25 | -16.5% | — | ||
| Q1 25 | -5.1% | — | ||
| Q3 24 | -16.7% | — | ||
| Q1 23 | — | -54.1% | ||
| Q2 22 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $-0.19 | — | ||
| Q3 25 | $0.19 | — | ||
| Q2 25 | $-0.16 | — | ||
| Q1 25 | $-0.06 | — | ||
| Q3 24 | — | — | ||
| Q1 23 | — | — | ||
| Q2 22 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.3M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $514.2M | $221.2M |
| Total Assets | $869.8M | $637.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $9.3M | — | ||
| Q4 25 | $13.5M | — | ||
| Q3 25 | $19.6M | — | ||
| Q2 25 | $8.4M | — | ||
| Q1 25 | $3.3M | — | ||
| Q3 24 | — | — | ||
| Q1 23 | — | $274.8M | ||
| Q2 22 | — | $363.1M |
| Q1 26 | — | — | ||
| Q4 25 | $314.3M | — | ||
| Q3 25 | $307.1M | — | ||
| Q2 25 | $316.9M | — | ||
| Q1 25 | $310.2M | — | ||
| Q3 24 | — | — | ||
| Q1 23 | — | — | ||
| Q2 22 | — | — |
| Q1 26 | $514.2M | — | ||
| Q4 25 | $391.2M | — | ||
| Q3 25 | $385.2M | — | ||
| Q2 25 | $369.9M | — | ||
| Q1 25 | $324.7M | — | ||
| Q3 24 | $1.0K | — | ||
| Q1 23 | — | $221.2M | ||
| Q2 22 | — | $100.7M |
| Q1 26 | $869.8M | — | ||
| Q4 25 | $854.4M | — | ||
| Q3 25 | $846.8M | — | ||
| Q2 25 | $856.5M | — | ||
| Q1 25 | $860.8M | — | ||
| Q3 24 | $1.0K | — | ||
| Q1 23 | — | $637.2M | ||
| Q2 22 | — | $783.1M |
| Q1 26 | — | — | ||
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.80× | — | ||
| Q2 25 | 0.86× | — | ||
| Q1 25 | 0.96× | — | ||
| Q3 24 | — | — | ||
| Q1 23 | — | — | ||
| Q2 22 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-26.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $42.1M | — | ||
| Q3 25 | $8.3M | — | ||
| Q2 25 | $9.3M | — | ||
| Q1 25 | $8.1M | — | ||
| Q3 24 | — | — | ||
| Q1 23 | — | $-26.3M | ||
| Q2 22 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q1 23 | — | — | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
